TERT and spinal cord glioma: In the present study, we revealed that the rate of TERT promoter mutations was 22.4% (13/58); additionally, this mutation was found mainly in H3-wildtype tumors (9/13), and was associated with a poor prognosis for grade II/III spinal cord gliomas.